TTBK1 and CK1 inhibitors restore TDP-43 pathology and avoid disease propagation in lymphoblast from Alzheimer’s disease patients
Neurodegenerative disease treatments are evolving rapidly, combining current therapies with innovative approaches. Discover the latest advances, including Molefy’s research, and explore effective strategies to improve patient outcomes.